Located on the Upper East Side, on Central Park
1220 Fifth Avenue, New York, NY 10029
Wednesday, October 12, 2022
Thursday, October 13, 2022
The New York Academy of Medicine has been a vital source for effective and, often, radical thought and action in healthcare and public health since its founding in 1847.
Located downtown, in the East Village
7 E 7th St, New York, NY 10003
Friday, October 14, 2022
Saturday, October 15, 2022
Sunday, October 16, 2022
The Great Hall at The Cooper Union is one of Manhattan’s most prestigious and long-lived auditoriums, and has hosted Horizons since 2015.
The Great Hall has been a center for public dialogue since its founding in 1858, having hosted such illustrious speakers as Abraham Lincoln, Mark Twain, Frederick Douglass, Susan B. Anthony, and more recently, Barack Obama.
3:15 PM
Mid-afternoon break
Lunch
4:30 PM
5:50 PM
MDMA-assisted therapy for PTSD and other indications
An update from MAPS PBC on its Phase 3 study for the use of MDMA-assisted therapy for the treatment of PTSD.
8:00 AM
Survey of recent and ongoing clinical research
An overview of the last year's findings, and studies to watch in the next year.
4:00 PM
Psilocybin-assisted therapy for alcohol-use disorder
Quantitative and qualitative results from a recently published trial investigating the effects of psilocybin vs. active placebo in alcohol use disorder.
1:00 PM
9:30 AM
10:15 AM
Doors open
Emerging indications for psychedelic therapies
Updates from ongoing research programs exploring psychedelic therapies for a variety of psychological and neurological disorders and illnesses.
9:00 AM
Adjourn
5:15 PM
Introductory remarks
2:45 PM
Why do psychedelic therapies work for multiple indications?
Three different scientists share their views on why similar psychedelic treatments seem to hold promise for a variety of seemingly disparate applications.
Closing grand panel and Q&A
The day's speakers answers questions from the audience and offer final thoughts.
Mid-morning break
6:00 PM
Psilocybin-assisted therapy for patients with cancer and end-of-life emotional distress
A review of the evidence to date and forthcoming studies investigating the potential of psilocybin-assisted therapy in end-of-life and palliative care.
12:15 PM
Closing remarks
11:30 AM
11:00 AM
Novel compounds, hopes and dreams
Thoughts on the invention and utility of new therapeutic psychedelic compounds.
Adjourn
4:00 PM
Mid-morning break
Territory, autonomy, culture and ancestral medicine in the Colombian Amazon
Riccardo Vitale, PhD
Miguel Evanjuanoy
Mazatec shamanism & the psychedelic renaissance
Nicholas Spiers
11:00 AM
Sunday, October 16th, 2022
8:30 AM - 5:00 PM
The Great Hall at Cooper Union
5:55 PM
12:30 PM
Studying ayahuasca users and facilitators in neoshamanic settings
Saleena Subaiya, MD, MSc
Kate O'Malley, MA
Finding right relationship with indigenous communities
Sandor Iron Rope
Lunch
9:30 AM
Psychedelics, creativity and quantum theory
Paul D. Miller
Doors open
1:00 PM
3:15 PM
4:30 PM
Introductory remarks
Lorena Dame
Kevin Balktick
Decolonizing psychedelics and indigenous reciprocity
Bia Labate, PhD
Joseph Mays, MSc
6:00 PM
Grand panel and Q&A
The Fireside Project: Real-time support for when time doesn't seem real
Joshua White
Hanifa Nayo Washington
12:15 PM
11:30 AM
2:30 PM
5:15 PM
Closing remarks
10:00 AM
8:30 AM
Mid-afternoon break
David Esselman, MBA
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Heidi Allen, MSW, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Corine de Boer, MD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Hailey Gilmore, MPH
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Michael Bogenschutz, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Gabby Agin-Liebes, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Manish Agrawal, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Paul Thambi, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Christopher Pittenger, MD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Sandeep Nayak, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Nicholas V. Cozzi, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Cody J. Wenthur, PharmD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Gül Dölen, MD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Ben Sessa, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
2:30 PM
Mixed results over miracles in psychedelic studies
While much of the the popular and even science media has heralded the results of certain high-profile psychedelic trials, a deeper look at the data and wider look across the literature often yields complicated and less than stellar results. What can we learn from a more skeptical approach to these publications?
Elias Dakwar, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Cody J. Wenthur, PharmD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Gül Dölen, MD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Ben Sessa, MD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed eu turpis tristique, lacinia nunc ac, ultrices eros.
Mary Cosimano, LMSW
Psychedelic Session Guide, Johns Hopkins University
Marcus Capone
New York State Assemblymember Patrick B. Burke
Assemblymember, New York State Assembly
Lieutenant General Martin R. Steele, US Marine Corps (Retired)
Co-Founder and Chief Executive Officer, Reason for Hope
Dialogues about the integration of psychedelic therapies into the policy, healthcare, and medicine systems.
This program is open to the public and is being held at the Great Hall at The Cooper Union.
Saturday, October 14th, 2023
8:00 AM - 6:00 PM
The Great Hall at Cooper Union
7 E 7th St, New York, NY 10003
Proof of vaccination required
8:00 AM
Doors open
9:30 AM
What will people think? Revealing public knowledge, belief, and perceptions of psychedelics
As the psychedelic field experiences exponential growth, many of its goals will be directly affected in significant ways by what the general public knows and believes about psychedelic substances. But aside from narrowly focused opinion research tied to specific political efforts, the field has not had an evidence-based understanding of those public perceptions and knowledge. Until now. In this session, Berkeley Center for the Science of Psychedelics executive director Imran Khan will present the findings of the inaugural Psychedelic Insight Poll, a national baseline survey that serves as the cornerstone of a multi-year opinion research program launched by BCSP in 2023 to provide the entire psychedelic community with data-driven insights into the general public's beliefs, hopes, fears, and questions about psychedelics and psychedelic therapies. The Psychedelic Insight Poll will be conducted annually to more fully understand public perceptions, track how those perceptions shift over time, and examine how current events, research discoveries, media and communications efforts, business strategies, and other activity in the field are influencing those shifts.
9:55 AM
Bringing psychedelics to Congress
More than fifty years after the passage of the Controlled Substances Act, a bipartisan team of legislators is asking their colleagues in US Congress to reevaluate the scheduling of certain psychedelics based on their potential for therapeautic applications.
10:30 AM
Possibilities and policies in federal engagement with psychedelics
For decades, the federal government has declined to adopt any policies specific to psychedelics. By default, prohibition and abstinence have been the official positions across every administration, but more than that-- psychedelics have simply garnered very little interest from government executives in recent decades. Now, with the swell of research centers, clinical trials, veteran advocacy, statewide and local regulatory initiatives, NIH grants, congressional action, and increasing patterns of usage among the public, the federal government may need to engage with questions unique to psychedelics in America. Join us to learn what it might look like for the many arms and agencies of the US government to address psychedelics at a time when their therapeutic potential is increasingly recognized, and the preeminence of prohibition is no longer presumed.
11:05 AM
Mid-morning break
11:30 AM
State initiatives to support psychedelic research and access
A dramatic expansion of psychedelic policy activism is underway at the state level. Over a dozen states have recently considered legislation addressing psychedelics, including bills proposing research funding, decriminalization, regulated adult use, and more. Join us to learn about the variety of initiatives underway, and how legislators and activists consider and design strategies unique to their state.
12:20 PM
Oregon Updates from the First Year of Regulated Access to Psilocybin Services
In November 2020, Oregon made history when its voters passed Ballot Measure 109, now known as the Oregon Psilocybin Services Act. This created a statewide regulatory system to support a market for supervised psilocybin experiences. This year, after two years of rulemaking and planning, the Oregon Health Authority (OHA) has now licensed manufacturers, analysis laboratories, training programs, facilitators, and service centers, fulfilling the vision established in Measure 109.
1:00 PM
Lunch
2:30 PM
Educating the next generation of psychedelic therapists
The presence of a skilled psychedelic facilitator and the establishment of rapport are key elements in the positive therapeutic outcomes. Ensuring high-quality industry-wide standards of training will be a priority for the success of this treatment modality. Join us to consider the strategies of preparing the next generation of psychedelic facilitators.
NiCole T. Buchanan, PhD
CEO, and Interim Board Chair, Board of Psychedelic Medicine and Therapies (BPMT)
3:10 PM
The legalities of religious use of psychedelics in America
In recent years, the medical model has reigned supreme over dialoague, legislation, and funding of psychedelics in America. And yet, there exists another uniquely American route to the legal use of psychedelics: religious practice, protected by the First Amendment. A patchwork of federal legislation and judicial precedents, including the unanimous UDV vs. USA Supreme Court ruling in 2006, uphold the ability to use psychedelics within sincere religious contexts. However, the existing legal affirmations were very hard-won for their petitioners, and there exists much gray area in determining to whom and how they apply, and much risk for group seeking clarity. In this session, we will consider the legal relationship between religious freedom and spiritual practices that use psychedelics.
4:00 PM
Mid-afternoon break
4:30 PM
Class, classism, and psychedelics in America
The much-touted "psychedelic rennaissance" of the last two decades has primarily been an upper middle class phenomenon. Throughout the non-indigenous psychedelic landscape, organizational leaders and executives, scientific investigators and study participants, media figures and spokespersons, gatekeepers and funders, and visitors to underground and offshore retreat centers typically come from similar affluent, educated, insular cultures. While there has been much discussion in recent years of social justice, equity, and access, these initiatives are rarely designed by the communities they seek to aid, and hard discussions about class and privilege are often swept under the rug of technocratic systems and metrics. Join us as we listen to leaders who seek to bring psychedelics into their communities on their own terms.
5:20 PM
Grand panel and Q&A
The day's speakers answers questions from the audience and offer final thoughts.
5:55 PM
Concluding remarks
6:00 PM
Adjourn
Classes + Workshops
Wednesday, October 11, 2023 and
Thursday October 12, 2023
at the New York Academy of Medicine
The Psychedelic Business Forum
Thursday October 12, 2023
at the New York Academy of Medicine
Science, Medicine, and Psychedelics
Friday, October 13, 2023
at the Great Hall at The Cooper Union
Psychedelics in America
Saturday, October 14, 2023
at the Great Hall at The Cooper Union
Psychedelics in the World
Sunday, October 15, 2023
at the Great Hall at The Cooper Union
our fifteenth conference
october 12-16, 2022
new york city
presented by horizons pbc, a public benefit corporation
thursday, october 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
wednesday, october 12, 2022
thursday, october 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
friday, october 14, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
saturday, october 15, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
sunday, october 16, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
sunday, october 16, 2022
the great hall at cooper union
new york city
presented by horizons pbc, a public benefit corporation
saturday, october 15, 2022
the great hall at cooper union
new york city
presented by horizons pbc, a public benefit corporation
friday, october 14, 2022
the great hall at cooper union
new york city
presented by horizons pbc, a public benefit corporation
our fifteenth conference
october 12-16, 2022
new york city
presented by horizons pbc, a public benefit corporation
thursday, october 13, 2022
the new york academy of medicine
new york city
presented by horizons pbc, a public benefit corporation
our fifteenth conference
october 12-16, 2022
new york city
presented by horizons pbc, a public benefit corporation
thursday, october 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
wednesday, october 12, 2022
thursday, october 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
friday, october 14, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
saturday, october 15, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
sunday, october 16, 2022
the great hall at cooper union
new york city
part of the fifteenth annual horizons conference
presented by horizons pbc, a public benefit corporation
Thursday, October 13, 2022
Briefings and dialogues about the growing psychedelics ecosystem for entrepreneurs, executives, and funders.
at The New York Academy of Medicine.
Wednesday, October 12, 2022
Thursday, October 13, 2022
Professional education classes with CE/CME credit for medical and health professionals with leading researchers and practitioners.
at The New York Academy of Medicine.
Friday, October 14, 2022
A briefing on psychedelic-assisted therapies, pharmacology, and neuroscience from leading researchers.
at The Great Hall at The Cooper Union.
Saturday, October 15, 2022
Dialogues about the present and future of psychedelics in medicine.
at The Great Hall at The Cooper Union.
Sunday, October 16, 2022
Dialogues about the role of psychedelics in traditional, contemporary, and global settings.
at The Great Hall at The Cooper Union.
Thursday, October 13, 2022
Briefings and dialogues about the growing psychedelics ecosystem for entrepreneurs, executives, and funders.
at The New York Academy of Medicine
Wednesday, October 12, 2022
Thursday, October 13, 2022
Professional education classes with CE/CME credit for medical and health professionals with leading researchers and practitioners.
at The New York Academy of Medicine
Friday, October 14, 2022
A briefing on psychedelic-assisted therapies, pharmacology, and neuroscience from leading researchers.
at The Great Hall at The Cooper Union
Saturday, October 15, 2022
Dialogues about the present and future of psychedelics in medicine.
at The Great Hall at The Cooper Union
Sunday, October 16, 2022
Dialogues about the role of psychedelics in traditional, contemporary, and global settings.
at The Great Hall at The Cooper Union
wednesday, october 12, 2022
thursday, october 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference presented by horizons pbc, a public benefit corporation
Briefings and dialogues about the growing psychedelics ecosystem for entrepreneurs, executives, and funders.
at The New York Academy of Medicine
A briefing on psychedelic-assisted therapies, pharmacology, and neuroscience from leading researchers.
at The Great Hall at The Cooper Union
friday, october 14, 2022
the great hall at the cooper union
new york city
part of the fifteenth annual horizons conference presented by horizons pbc, a public benefit corporation
Wednesday, October 12, 2022
Professional education classes with CE/CME credit for medical and health professionals with leading researchers and practitioners.
at The New York Academy of Medicine
wednesday, October 12, 2022
thursday, October 13, 2022
the new york academy of medicine
new york city
part of the fifteenth annual horizons conference presented by horizons pbc, a public benefit corporation
Dialogues about the present and future of psychedelics in medicine.
at The Great Hall at The Cooper Union
saturday, october 15, 2022
the great hall at the cooper union
new york city
part of the fifteenth annual horizons conference presented by horizons pbc, a public benefit corporation
Dialogues about the role of psychedelics in traditional, contemporary, and global settings.
at The Great Hall at The Cooper Union
sunday, october 16, 2022
the great hall at the cooper union
new york city
part of the fifteenth annual horizons conference presented by horizons pbc, a public benefit corporation
We respect your privacy.
Thank you for signing up to our newsletter.
Oops, there was an error, please try again later.
© 2007-2024
The Horizons Center PBC, Inc. is a public benefit corporation.